Dr. Carrolee Barlow, M.D., Ph.D.

Director

Dr. Carrolee Barlow, M.D., Ph.D., was appointed to the Board of Directors in June 2018. Dr. Barlow is an expert in neuroscience and neurodegeneration, and is currently the Chief Executive Officer of the Parkinson’s Institute and Clinical Center, Sunnyvale, California.

Dr. Barlow’s previous work has spanned clinical care, laboratory and clinical research, academia, and industry. She is the former Chief Scientific Officer and Chief Medical Officer of BrainCells, Inc., a biotechnology company focused on the discovery and development of small molecules that stimulate adult hippocampal neurogenesis for the treatment of neurological and psychiatric disease. Prior to BrainCells, she served as the Director of Molecular Neuroscience and Therapeutic Area Head for Stroke and Neurodegeneration at Merck Research Laboratories where she was responsible for neuroscience biology, global exploratory, licensing, and development efforts. Dr. Barlow has held a faculty position in the Laboratory of Genetics at the Salk Institute for Biological Studies in La Jolla, California. She also serves as an advisory board member for several biotechnology companies and disease foundations advancing therapies for rare diseases and disorders of the central nervous system.

Dr. Barlow received her Bachelor of Arts in English from The University of Utah and Doctor of Medicine from The University of Utah School of Medicine. In addition, she received her Doctor of Philosophy in molecular and developmental biology from The Karolinska Medical Nobel Institute in Stockholm, Sweden.